Licensing, Mergers & Acquisitions

Proprietary In-Licensing Capability

• Geller Biopharm, in conjunction with the Frankel Group, offers a proprietary product for systematically identifying and acquiring novel compounds or companies utilizing a comprehensive array of resources.
• Senior members of our team work in close conjunction with our clients, to conduct an initial broad scientific and commercial review of targeted therapeutic area(s), and build a list of appropriate companies and products for acquisition.
• Leveraging our global relationships, Geller Biopharm helps guide internal due diligence, deal structure and execution with targeted compounds/companies.